AKAN
Akanda CorpNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.73M
P/E Ratio
0.00
EPS
$154.84
Beta
1.73
52W High
$26.88
52W Low
$0.51
50-Day MA
$0.95
200-Day MA
$9.73
Dividend Yield
—
Profit Margin
-266.30%
Forward P/E
—
PEG Ratio
—
About Akanda Corp
Akanda Corporation. The company is headquartered in New Romney, the United Kingdom.
Fundamentals
| Revenue (TTM) | 836,660 |
| Gross Profit (TTM) | 208,380 |
| EBITDA | $-3.68M |
| Operating Margin | -443.80% |
| Return on Equity | -60.90% |
| Return on Assets | -28.70% |
| Revenue/Share (TTM) | $6.92 |
| Book Value | $22.67 |
| Price-to-Book | 0.50 |
| Price-to-Sales (TTM) | 2.06 |
| EV/Revenue | 0.441 |
| EV/EBITDA | -0.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 21.90% |
| Shares Outstanding | $2.40M |
| Float | 144,780 |
| % Insiders | 0.00% |
| % Institutions | 2.27% |
Data last updated: 4/7/2026